Post by
cheetio on Oct 11, 2015 10:42am
Red it
Dr. Colin P. Dinney...quote.."If these results can be duplicated in a study with a .....truly.... refractory population...... and with a .....biopsy at the study endpoint.... findings are "noteworthy," but he had reservations about the study design, pointing out that 25% of the patients did not receive a second course of BCG
Comment by
cheetio on Oct 11, 2015 10:45am
has reservations about the study design, pointing out that 25% of the patients did not receive a second course of BCG
Comment by
noinstinct89 on Oct 11, 2015 1:24pm
Even if this cold be an issue... I hope you heard about "accelerated approval"? -> BCG vs. MCNA after approval. Even this would be a solution to his "reservation". But who knows, if the Adcom also sees it like Dr. D.... ;) I don't.
Comment by
cheetio on Oct 11, 2015 7:25pm
Sometin's gotta keep the fairytale goin....... reverse split blank cheque should do it